The U.S. House of Representatives is passing a series of bills this week to address opioid abuse and pain management. One bill would create a national task force on opioid policies, which advocates hope will spur a major overhaul to the government’s approach to addiction, including updating best practices for pain management and prescribing pain medication. Another bill would require the FDA to work closely with experts before making opioid product approval and labeling decisions, and to make recommendations regarding education programs for prescribers. Lexology provides a description of each of these bills.